These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 162689)

  • 21. [Prevention of thromboembolism with a low-dose heparin regimen in acute stroke].
    Mück AO; Heinrich F
    Med Klin (Munich); 1992 Aug; 87(8):422-7. PubMed ID: 1406475
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluating A.P.T.T.
    Norris MK
    Nursing; 1992 Apr; 22(4):28. PubMed ID: 1570097
    [No Abstract]   [Full Text] [Related]  

  • 23. [Heparin management by activated coagulation time during cardiopulmonary bypass].
    Shikano K; Shinpo H; Nasu M; Morimoto T; Suzuki T; Yada I; Kusagawa M
    Kyobu Geka; 1981; 34(12):934-7. PubMed ID: 7349352
    [No Abstract]   [Full Text] [Related]  

  • 24. Results of low-dose heparin prophylaxis of venous thrombosis considering plasma heparin and anti-thrombin III concentration.
    Tilsner V; Müller U; Reuter H; Raedler A
    Thromb Res; 1980 Feb 1-15; 17(3-4):519-25. PubMed ID: 7368173
    [No Abstract]   [Full Text] [Related]  

  • 25. Heparin, heparin plus ASA and dipyridamole, and arteriovenous fistula as adjuvant methods to prevent rethrombosis after venous thrombectomy. Experimental study in rabbits.
    Rollo HA; Maffei FH; Yoshida WB; Lastória S; Curi PR; Mattar L
    Int Angiol; 1991; 10(2):88-94. PubMed ID: 1861092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention and therapy of postoperative thrombosis and embolism.
    Röggla M; Wagner A; Malzer R; Gamper G; Janata K; Röggla G
    Acta Anaesthesiol Scand Suppl; 1997; 111():217-9. PubMed ID: 9421020
    [No Abstract]   [Full Text] [Related]  

  • 27. [Monitoring of heparin therapy with activated recalcification time].
    Lutze G; Schlote A; Urbahn H
    Z Gesamte Inn Med; 1981 Feb; 36(4):102-6. PubMed ID: 7222858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma heparin values and hemostasis in equids after subcutaneous administration of low-dose calcium heparin.
    Gerhards H; Eberhardt C
    Am J Vet Res; 1988 Jan; 49(1):13-8. PubMed ID: 3354959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total knee replacement in a patient with lupus anticoagulant.
    Bhagia UT; Corpe RS; Steflik D
    J South Orthop Assoc; 1997; 6(3):231-4. PubMed ID: 9322205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Heparin and antiheparin in childhood. 3. Heparin level measurements and their importance in heparin monitoring].
    Domula M; Weissbach G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(1):146-61. PubMed ID: 6192049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physician-guided treatment compared with a heparin protocol for deep vein thrombosis.
    Elliott CG; Hiltunen SJ; Suchyta M; Hull RD; Raskob GE; Pineo GF; Jensen RL; Yeates S; Kitterman N
    Arch Intern Med; 1994 May; 154(9):999-1004. PubMed ID: 8179457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving use of heparin in acute deep venous thrombosis.
    Gold JA; Ferguson CJ; Williams NF; Braun SK
    Wis Med J; 1996 May; 95(5):311-2. PubMed ID: 8936037
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of postoperative pulmonary embolism (author's transl)].
    Heinrichs C
    Zentralbl Gynakol; 1981; 103(8):425-33. PubMed ID: 7269878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombin time dilution test: a simple method for the control of heparin therapy.
    Pizzuto J; García-Méndez S; de-la-Paz Reyna M; Morales MR; Avilés A; Zavala B; Gaos C
    Thromb Haemost; 1979 Dec; 42(4):1276-85. PubMed ID: 542933
    [No Abstract]   [Full Text] [Related]  

  • 35. Approaches to deep venous thrombosis and pulmonary embolism in aging patients.
    Trulock EP
    Geriatrics; 1988 Feb; 43(2):101-2, 104, 106 passim. PubMed ID: 3276578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The optimization of the heparin prophylaxis of postoperative thromboembolic complications].
    Nozdrachev IuI
    Vestn Khir Im I I Grek; 1995; 154(2):61-5. PubMed ID: 8540191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of a new potent heparin. 7th communication: A comparative study of a new potent heparin in human after i.v. application.
    Bhargava AS; Wendt H; Günzel P
    Arzneimittelforschung; 1981; 31(2):386-8. PubMed ID: 7194658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subcutaneous vs intravenous heparin in the treatment of deep venous thrombosis--a randomized clinical trial.
    Pini M; Pattachini C; Quintavalla R; Poli T; Megha A; Tagliaferri A; Manotti C; Dettori AG
    Thromb Haemost; 1990 Oct; 64(2):222-6. PubMed ID: 2270531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Modification of the global coagulation tests for the dog. Significance for the monitoring of heparin therapy].
    Mischke R; Nolte I
    Tierarztl Prax; 1991 Oct; 19(5):561-6. PubMed ID: 1759273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Perioperative prevention of thromboembolism].
    Schneider MU; Hahn EG
    Internist (Berl); 1992 Jun; 33(6):410-7. PubMed ID: 1321095
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.